AOL Money & Finance

Option Update: Elan Corp volatility up into positive Phase 2 Alzheimer's data

Posted Jun 17th 2008 9:18AM by Paul FosterPaul Foster RSS Feed
Filed under: Major movement, Options

More

Elan Corp (NYSE: ELN) is recently trading at $28.41 in pre-open trading, above its close of $27.11 Monday.

ELN and Wyeth (NYSE: WYE)'s Bapineuzumab (Alzheimer's treatment) Phase 2 trial results were positive. Detailed results of the trial will be presented at the International Conference on Alzheimer's Disease on July 29, 2008.

ELN July option implied volatility is at 107, October is at 82; above its 26-week average of 68 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: Elan Corp, ElanCorp, eln, inthenews, option implied volatilit, OptionImpliedVolatilit, wye, Wyeth

Symbol Lookup
IndexesChangePrice
DJIA+30.6910,464.40
NASDAQ+6.872,176.05
S&P 500+4.981,110.63

Last updated: November 27, 2009: 01:09 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    • My Portfolio
    • Create a New Portfolio

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines